Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2008 | Volume: 3 | Issue: 2 | Page No.: 75-83
DOI: 10.3923/jpt.2008.75.83
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Antihepatotoxic Effects of Boerhaavia diffusa L. on Antituberculosis Drug, Rifampicin Induced Liver Injury in Rats

M. Muthulingam

Abstract:
The aim of the present study was to investigate the antihepatotoxic effect of aqueous leaf extract of Boerhaavia diffusa (BDEx) on rifampicin induced liver injury. The activities of serum hepatic marker enzymes viz., aspartate aminotransferase (AST, 95.30±2.96), alanine aminotransferase (ALT, 51.27±2.52) and alkaline phosphatase (ALP, 167.04±2.59), levels of bilirubin (0.96±0.01), cholesterol (95.88±3.29) and protein (8.43±0.10) were estimated in control rats. Significant elevation of serum hepatic marker enzymes (AST, 254.59±3.10; ALT, 181.95±2.45; ALP, 316.57±2.35), bilirubin (3.46±0.28) and cholesterol (151.09±1.15) whereas protein (5.28±0.07) level decreased in rats treated with rifampicin (1 g kg-1 b. wt. orally one day only). Oral administration of BDEx (250 and 500 mg kg-1 b. wt. once daily for 28 days) and silymarin to rifampicin induced liver injury rats caused significantly (p< 0.05) attenuated the aforementioned parameters. The maximum antihepatotoxic effect against rifampicin induced liver injury was achieved with BDEx 500 mg kg-1 b. wt. but doses higher than 500 mg kg-1 b. wt. were less effective. These results are compared to the reference hepatoprotective agent silymarin. These results suggest that BDEx possess the antihepatotoxic activity against rifampicin induced liver injury.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

M. Muthulingam , 2008. Antihepatotoxic Effects of Boerhaavia diffusa L. on Antituberculosis Drug, Rifampicin Induced Liver Injury in Rats. Journal of Pharmacology and Toxicology, 3: 75-83.

DOI: 10.3923/jpt.2008.75.83

URL: https://scialert.net/abstract/?doi=jpt.2008.75.83

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom